SR-16435
SR-16435 is a chemical compound that is often used in scientific research. It is a member of the benzodiazepine class of drugs, which are known for their sedative and anxiolytic effects. However, unlike most benzodiazepines, SR-16435 is not used clinically due to its high potency and potential for abuse.
Chemistry[edit]
SR-16435 is a benzodiazepine, a class of drugs that are typically characterized by a core structure of a benzene ring fused to a diazepine ring. The chemical structure of SR-16435 is unique among benzodiazepines due to the presence of a fluorine atom at the 7th position of the diazepine ring, which is believed to contribute to its high potency.
Pharmacology[edit]
Like other benzodiazepines, SR-16435 acts as a positive allosteric modulator of the GABA_A receptor, the major inhibitory neurotransmitter receptor in the brain. This means that it enhances the effect of GABA at this receptor, leading to increased inhibitory effects on neuronal activity. This is believed to be the mechanism underlying the sedative and anxiolytic effects of benzodiazepines.
Research Use[edit]
Due to its high potency, SR-16435 is primarily used in scientific research rather than clinical practice. It is often used in studies investigating the pharmacology of benzodiazepines and the GABA_A receptor. For example, it has been used in studies investigating the role of the GABA_A receptor in anxiety and sleep disorders.
Potential for Abuse[edit]
Like other benzodiazepines, SR-16435 has a high potential for abuse. This is due to its ability to produce feelings of relaxation and euphoria, which can lead to psychological dependence. For this reason, it is classified as a Schedule IV controlled substance in the United States.
See Also[edit]
-
SR-16435
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

